Pre-implantation Genetic Screening (PGS) is a technique to assess the karyotype (chromosome number) of the embryos. It aims to detect embryos with normal chromosome complement for embryo transfer and exclude the transfer of aneuploid embryos.
Below listed are the indicators of PGS:
The first step in this procedure is stimulation of the ovaries using hormonal injections, to produce multiple eggs. The injections are usually started on the second day of the womans period after a baseline ultrasonography and have to be taken daily for about 10-12 days. During these 10-12 days, sonography is done every 3-4 days to monitor response. Once the follicles are of appropriate size, trigger injection is planned.
The next step is egg retrieval, which is done in the operation theatre with ultrasound guidance and under anaesthesia. After retrieving the eggs, the embryologist checks the total number and maturity.
After the egg retrieval, fertilisation of the eggs can be done in 2 ways:
The fertilised eggs (embryos) are allowed to grow in the laboratory in precise culture conditions upto the blastocyst stage (Day5 or Day6). During this period, the embryologist examines the embryo at specific times every day to check for growth.
Once the embryos have reached the blastocyst stage, the embryologist takes a biopsy (removes a few cells) for testing. Embryo biopsy is a highly specialised technique and only highly trained and validated embryologists can carry it out.
After the biopsy, the material is sent to the genetic testing laboratory for PGS.
After receiving the PGS result from the Genetic Testing Laboratory, those embryos which have a normal karyotype are selected for transfer. At one time, only one or two embryos are transferred to the uterus to avoid the possibility of higher order multiple pregnancy.
Other normal embryos can be kept frozen for future use.
The pregnancy test is done 10 days after the embryo transfer.